FDA in­spec­tion back­log tops 1,000 — and could last for years — as House hear­ing rais­es se­ri­ous con­cerns

A US House of Rep­re­sen­ta­tives sub­com­mit­tee on Tues­day reignit­ed bi­par­ti­san angst around the FDA’s drug man­u­fac­tur­ing in­spec­tion back­log and at­tempts to im­prove its in­spec­tions process …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER